India is set to launch its first approved dengue vaccine, Qdenga, in 2027, following recent regulatory clearance. Coverage across outlets notes that Qdenga is intended to prevent dengue illness and will be the country’s first approved vaccine of its kind.
The Hindu reports that in July 2026 the vaccine receives marketing authorisation from India’s Central Drugs Standard Control Organisation (CDSCO). The authorisation covers people aged 4 to 60 years, aligning with the age range highlighted in the reporting. India Today also frames the announcement around the expected 2027 arrival and explains what Qdenga is and how it works.
While both sources focus on the timeline for India and the identity of the vaccine, their emphasis differs: one stresses the regulator’s approval and the eligible age group, while the other focuses more on general background on the vaccine’s purpose and mechanism. Both present 2027 as the target year for introduction in India.
